Home › Spinal Muscular Atrophy › Arizona › Phoenix
Spinal Muscular Atrophy clinical trials in Phoenix, AZ
4 studies for Spinal Muscular Atrophy are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RecruitingPhase 2
- Phoenix Children's Hospital, Phoenix
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
RecruitingPhase 1
- St. Joseph's Hospital and Medical Center - Barrow Neurological Institute, Phoenix
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Recruiting
- Barrow Neurological Institute, Phoenix
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
RecruitingObservational study
- Phoenix Children's Hospital, Phoenix
About Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) attacks nerve cells in the spinal cord, weakening voluntary muscles. Read about the genetics, types, and what may help.
More about Spinal Muscular Atrophy on MedlinePlus
Spinal Muscular Atrophy trials in other cities
- Mountain View, CA9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Chicago, IL6 studies
- Norfolk, VA6 studies
- Grand Rapids, MI6 studies
- Boston, MA5 studies
- Houston, TX5 studies
- Little Rock, AR4 studies
- Lewisville, TX4 studies
- Aurora, CO4 studies
- Memphis, TN3 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.